Case Study
A Tech-enabled Service To Improve Adherence And Protocol Compliance In A Clinical Trial

The Phase 2 trial for CLE-100 in MDD uses Scene Health’s video-based adherence system to ensure compliance, prevent misuse, and improve data reliability. A previous trial (CLEO) showed 97.4% adherence and 89.2% retention, demonstrating the effectiveness of this approach.
Speakers
No items found.